HYTN Innovations Inc (TSE:HYTN) has released an update.
HYTN Innovations Inc., a Canadian company specializing in products with psychoactive ingredients like cannabis and psilocybin, has successfully passed a GMP audit by Australia’s Therapeutic Goods Administration, paving the way for international expansion. This achievement makes HYTN one of the select Canadian companies authorized to package and label finished cannabis goods for the global medical market. With GMP certification imminent, HYTN is well-positioned to tap into the growing international demand for compliant cannabis products and explore new partnerships.
For further insights into TSE:HYTN stock, check out TipRanks’ Stock Analysis page.
